Transient increased immunoglobulin levels in a hyper-IgM syndrome patient with COVID-19 infection

Background: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the world. This zoonotic-enveloped virus is primarily transmitted through inhalation. Infected people are commonly asymptomatic or manifest mild symptoms, including fever, cough, diarrhea, and fatigue...

Full description

Saved in:
Bibliographic Details
Published inAllergologia et immunopathologia Vol. 49; no. 6; pp. 63 - 66
Main Authors Safarirad, Molood, Ganji, Ali Abbaszadeh, Nazari, Farzad, Yazdani, Reza, Abolhassani, Hassan, Vosughi Motlagh, Ahmad
Format Journal Article
LanguageEnglish
Spanish
Published Murcia Codon Publications 01.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people around the world. This zoonotic-enveloped virus is primarily transmitted through inhalation. Infected people are commonly asymptomatic or manifest mild symptoms, including fever, cough, diarrhea, and fatigue. However, it may lead to severe patterns associated with multiple organ failure in individuals with an impaired immune system. Objective: Here we report a 7-year-old girl with hyper-immunoglobulin M (IgM) (HIgM) phenotype, admitted to the hospital emergency department with fever, cough, and pneumonia symptoms because of the COVID-19 infection. Coronavirus infection was confirmed by a positive real-time polymerase chain reaction test. Surprisingly, serum levels of both IgG and IgA of the patient were transiently normalized during the COVID-19 infection when tested prior to the monthly injection of intravenous immunoglobulin. After she recovered from the COVID infection, her immunoglobulin levels returned to the primary stage and she demonstrated HIgM phenotype. Conclusion: Since this transient increase in the levels of immunoglobulins was solely observed during the COVID-19 infection, and no other infectious episodes were diagnosed in the patient, clarifying the exact cause would help to understand in a better manner the implications and specification of humoral immunity in patients with primary antibody deficiencies.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0301-0546
1578-1267
0301-0546
1578-1267
DOI:10.15586/aei.v49i6.92